AFAP1 and breast carcinoma: Therefore, further investigation into the relationship between aberrant expression of AFAP1‐AS1 and breast cancer progression will enhance our comprehension of the pathogenesis of breast cancer and facilitate identification of more reliable clinical therapeutic targets.